×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Depression Screening Mental Health Market

ID: MRFR/Pharma/2518-CR
128 Pages
Kinjoll Dey
October 2023

Depression Screening Market Research Report Information by Indication (Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, and Others), by Diagnosis (Psychological Tests, Blood Tests, Pharmacogenomic Testing, and Others), by End User (Hospitals and Clinics, Home-based, and Research and Academic Institutes), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Depression Screening Mental Health Market Infographic
Purchase Options

Depression Screening Mental Health Market Summary

As per MRFR analysis, the Depression Screening Mental Health Market was estimated at 730.52 USD Million in 2024. The Depression Screening industry is projected to grow from 773.41 USD Million in 2025 to 1368.43 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.87 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Depression Screening Mental Health Market is experiencing a transformative shift towards integrated and preventive care solutions.

  • Technological integration is reshaping the landscape of depression screening, enhancing accuracy and accessibility.
  • North America remains the largest market, driven by increased awareness and robust healthcare infrastructure.
  • The treatment segment is witnessing rapid growth, particularly in telehealth services, which offer convenient access to mental health resources.
  • Rising prevalence of depression and advancements in screening technologies are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 730.52 (USD Million)
2035 Market Size 1368.43 (USD Million)
CAGR (2025 - 2035) 5.87%

Major Players

Pearson (GB), Beck Institute for Cognitive Behavior Therapy (US), Mind Diagnostics (US), Ginger (US), Talkspace (US), Lyra Health (US), Cerebral (US), BetterHelp (US), Headspace Health (US)

Depression Screening Mental Health Market Trends

The Depression Screening Mental Health Market is currently experiencing a notable evolution, driven by an increasing awareness of mental health issues and the importance of early detection. This market appears to be expanding as healthcare providers and organizations recognize the necessity of implementing effective screening tools. The integration of technology into mental health services, such as telehealth and mobile applications, seems to enhance accessibility and convenience for individuals seeking support. Furthermore, the growing emphasis on preventive care may lead to a more proactive approach in addressing depression, thereby fostering a culture of mental wellness. In addition, the ongoing collaboration between various stakeholders, including healthcare professionals, policymakers, and technology developers, indicates a collective effort to improve mental health outcomes. This collaboration may result in the development of innovative screening methods and resources tailored to diverse populations. As the Depression Screening Mental Health Market continues to evolve, it is likely that new strategies will emerge, focusing on personalized care and the integration of mental health services into primary healthcare settings. Overall, the market appears poised for growth, reflecting a broader societal shift towards prioritizing mental health and well-being.

Technological Integration

The incorporation of technology into the Depression Screening Mental Health Market is becoming increasingly prevalent. Digital tools, such as mobile applications and online platforms, facilitate easier access to screening resources. This trend suggests that individuals may benefit from more convenient and user-friendly options for assessing their mental health.

Focus on Preventive Care

There is a growing emphasis on preventive care within the Depression Screening Mental Health Market. This shift indicates a proactive approach to mental health, where early detection and intervention are prioritized. Such a focus may lead to improved outcomes and a reduction in the long-term impact of depression.

Collaborative Efforts

The Depression Screening Mental Health Market is witnessing enhanced collaboration among various stakeholders. Healthcare providers, policymakers, and technology developers are increasingly working together to create comprehensive screening solutions. This trend suggests a unified effort to address mental health challenges and improve access to necessary resources.

Depression Screening Mental Health Market Drivers

Market Growth Projections

The Global Depression Screening Market Industry is projected to experience substantial growth over the coming years. With a market value of 0.73 USD Billion in 2024, it is anticipated to reach 1.37 USD Billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.86% from 2025 to 2035. This growth is driven by various factors, including the rising prevalence of depression, increased awareness of mental health, and advancements in screening technologies. As stakeholders in the healthcare sector recognize the importance of early detection and intervention, the market is likely to expand, presenting opportunities for innovation and investment.

Rising Prevalence of Depression

The increasing prevalence of depression globally serves as a primary driver for the Global Depression Screening Market Industry. Recent statistics indicate that approximately 264 million individuals are affected by depression worldwide, highlighting a pressing need for effective screening methods. As awareness of mental health issues grows, healthcare systems are prioritizing early detection and intervention strategies. This trend is likely to bolster the demand for screening tools and services, contributing to the market's projected growth from 0.73 USD Billion in 2024 to an estimated 1.37 USD Billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.86% from 2025 to 2035.

Government Initiatives and Funding

Government initiatives aimed at improving mental health services significantly influence the Global Depression Screening Market Industry. Various countries are implementing policies that promote mental health awareness and allocate funding for screening programs. For instance, national health services are increasingly integrating depression screening into routine healthcare practices, thereby enhancing accessibility. Such initiatives not only encourage healthcare providers to adopt screening protocols but also facilitate the development of innovative screening tools. This supportive environment is expected to drive market growth, as evidenced by the projected increase in market value from 0.73 USD Billion in 2024 to 1.37 USD Billion by 2035.

Increased Awareness of Mental Health

The growing awareness of mental health issues among the global population significantly drives the Global Depression Screening Market Industry. Public campaigns and educational programs are fostering a better understanding of depression, its symptoms, and the importance of early detection. This heightened awareness encourages individuals to seek screening and treatment, thereby increasing the demand for screening services. As mental health becomes a priority in public health discussions, healthcare providers are more likely to implement screening protocols. The market is projected to grow from 0.73 USD Billion in 2024 to 1.37 USD Billion by 2035, reflecting the positive correlation between awareness and market expansion.

Integration of Screening in Primary Care

The integration of depression screening into primary care settings is a vital driver for the Global Depression Screening Market Industry. Healthcare providers are increasingly recognizing the importance of addressing mental health within general health services. This integration allows for early identification and management of depression, improving overall patient care. As primary care physicians adopt standardized screening tools, the demand for these tools is expected to rise. The market's growth trajectory, from 0.73 USD Billion in 2024 to 1.37 USD Billion by 2035, illustrates the potential impact of this integration on enhancing screening practices and expanding market opportunities.

Technological Advancements in Screening Tools

Technological advancements play a crucial role in shaping the Global Depression Screening Market Industry. The integration of artificial intelligence and machine learning into screening tools enhances their accuracy and efficiency, allowing for more effective identification of depression symptoms. Innovations such as mobile applications and telehealth platforms facilitate remote screening, making it easier for individuals to access mental health services. These advancements not only improve patient outcomes but also expand the market reach, as more healthcare providers adopt these technologies. The anticipated growth from 0.73 USD Billion in 2024 to 1.37 USD Billion by 2035 underscores the impact of technology on market dynamics.

Market Segment Insights

By Application: Screening (Largest) vs. Treatment (Fastest-Growing)

In the Depression Screening Mental Health Market, the application segment is primarily divided into screening, diagnosis, monitoring, treatment, and research. Among these, screening emerges as the largest segment, driving significant revenue due to its essential role in early detection of depression. Conversely, the treatment segment is noted for its rapid growth, reflecting the increasing demand for effective methodologies addressing mental health issues.

Screening (Dominant) vs. Treatment (Emerging)

Screening, as the dominant segment in the market, encompasses various techniques and tools aimed at identifying individuals at risk of depression. This segment emphasizes early intervention to reduce the overall burden of mental health disorders. On the other hand, the treatment segment represents an emerging field reflecting advances in therapeutic practices, increasing acceptance of mental health treatments, and a growing focus on personalized care. The rapid growth in this segment can be attributed to the integration of innovative therapeutic approaches, including pharmacological and psychological interventions, responding to a rising awareness and need for effective mental health resources.

By End Use: Hospitals (Largest) vs. Telehealth (Fastest-Growing)

The Depression Screening Mental Health Market displays a diverse array of end-use segments, with hospitals commanding the largest market share. Typically, hospitals have robust resources and comprehensive facilities, enabling effective and timely depression screenings. Clinics follow closely, with a significant share as they provide specialized mental health services tailored to local populations. Home care, telehealth, and community health segments reflect emerging dynamics within the market, catering to a population increasingly seeking accessible mental health services.

Hospitals (Dominant) vs. Telehealth (Emerging)

Hospitals serve as the dominant players in the Depression Screening Mental Health Market, leveraging their extensive infrastructure and expertise to deliver high-quality mental health services. They are equipped with interdisciplinary teams that collaborate to address complex cases of depression. In contrast, the telehealth segment is gaining momentum, fueled by advancements in technology and a growing demand for remote healthcare solutions. Telehealth offers flexibility and accessibility, particularly advantageous for individuals in remote areas or those unable to attend traditional visits. As a result, while hospitals remain steadfast in their market position, telehealth is emerging as a vital alternative, bridging gaps in care and reaching underserved populations.

By Age Group: Adults (Largest) vs. Children (Fastest-Growing)

The Depression Screening Mental Health Market is significantly influenced by age demographics, with adults commanding the largest share. This adult segment encompasses individuals aged 18 to 64, who are increasingly seeking effective screening methods due to rising awareness of mental health issues. Conversely, the children segment is emerging as a focal point, driven by the growing recognition of mental health challenges in younger populations. As awareness continues to expand, these two segments present contrasting market positions in terms of share and growth. Growth trends indicate a promising trajectory for the child and adolescent segments as mental health awareness initiatives lead to increased screening adoption. Policy changes, school-based mental health programs, and parental advocacy are driving this growth. For adults, there is a steady demand for effective screening solutions, driven by a growing emphasis on mental well-being and early intervention strategies. These trends are likely to shape the market as it responds to the unique needs of each age group.

Adults (Dominant) vs. Children (Emerging)

In the Depression Screening Mental Health Market, adults serve as the dominant age group, primarily due to their higher incidence rates of depressive disorders and stronger engagement with mental health services. Adults typically have better access to the necessary resources and are more likely to seek professional help. Meanwhile, children represent an emerging segment that is rapidly gaining attention with increasing advocacy for mental health screening in schools. Recognized as a vulnerable population, children are now being targeted for early intervention initiatives. This focus on children enhances their market potential, as schools and healthcare providers emphasize the necessity for mental health screenings. Overall, both segments reflect crucial demographics in mental health care evolution.

By Method of Screening: Clinical Assessment (Largest) vs. Digital Tools (Fastest-Growing)

In the Depression Screening Mental Health Market, the screening methods showcase distinct distributions in market engagement. Clinical Assessment stands out as the largest segment, representing a substantial share of the market. This method is preferred in traditional healthcare settings, where professionals conduct thorough evaluations. Self-Assessment and Telephonic Screening follow, but Digital Tools are emerging as a notable competitor, appealing to a tech-savvy demographic seeking convenience and privacy in their mental health screenings.

Clinical Assessment (Dominant) vs. Digital Tools (Emerging)

Clinical Assessment remains the dominant method in the Depression Screening Mental Health Market, characterized by face-to-face interactions with healthcare professionals who administer standardized tests and evaluate patients comprehensively. This method ensures an accurate diagnosis and a tailored treatment plan. In contrast, Digital Tools are gaining traction rapidly, funded by advances in technology and a shift towards self-care. These tools are often interactive apps or online platforms that allow individuals to perform self-assessments at their convenience, appealing especially to younger, digital-native populations. This evolving dynamic reflects a broader trend towards integrating technology into mental health care, highlighting the increasing demand for accessible and user-friendly mental health solutions.

By Severity of Depression: Mild (Largest) vs. Severe (Fastest-Growing)

In the Depression Screening Mental Health Market, the distribution of severity levels reveals that 'Mild' depression constitutes a substantial share, establishing itself as the largest segment. This is attributed to the rising awareness and increasing screenings leading to early detection and management. 'Moderate' and 'Chronic' segments follow, but 'Severe' depression is gaining traction due to heightened emphasis on addressing this severe mental health condition. Overall, the market is evolving with a comprehensive range of screening tools targeting varying severity levels, which affects the treatment pathways chosen by healthcare providers. Growth trends indicate a significant shift towards recognizing 'Severe' depression as one of the fastest-growing segments. The escalating prevalence of depression, accelerated by social factors and economic stressors, has pushed the focus towards effective screening for severe cases. Healthcare professionals are increasingly integrating advanced technological tools that facilitate early detection, enabling timely interventions. Additionally, there's growing support for mental health initiatives, propelling awareness and improving access to screening, which significantly impacts the growth trajectory of 'Severe' depression screening initiatives.

Mild: Dominant vs. Severe: Emerging

The 'Mild' segment remains the dominant player in the Depression Screening Mental Health Market, characterized by its high prevalence and early identification practices. Individuals in this category often exhibit mild symptoms that can be effectively managed through various interventions, including counseling and lifestyle modifications. Awareness campaigns and community screenings have significantly boosted the recognition of this segment. Conversely, the 'Severe' segment is emerging rapidly as it encompasses individuals with pronounced symptoms requiring intensive intervention. This segment is marked by increased hospitalizations and treatment modalities tailored to severe cases. Factors driving growth in the 'Severe' illness segment include rising healthcare expenditures, advances in screening technologies, and a deepening understanding of mental health, reflecting a broader societal shift towards comprehensive mental health care.

Get more detailed insights about Depression Screening Mental Health Market

Regional Insights

North America : Market Leader in Mental Health

North America is poised to maintain its leadership in the Depression Screening Mental Health Market, holding a significant market share of $365.26M in 2025. The region's growth is driven by increasing awareness of mental health issues, advancements in telehealth technologies, and supportive regulatory frameworks. The demand for effective screening tools is further fueled by rising incidences of depression and anxiety, prompting healthcare providers to adopt innovative solutions. The competitive landscape in North America is robust, featuring key players such as Talkspace, BetterHelp, and Ginger. These companies are leveraging technology to enhance accessibility and effectiveness in mental health care. The U.S. leads the market, supported by a strong healthcare infrastructure and a growing emphasis on mental health initiatives. The presence of established organizations fosters a dynamic environment for innovation and collaboration in mental health services.

Europe : Emerging Market for Mental Health

Europe is witnessing a significant transformation in the Depression Screening Mental Health Market, with a market size of €215.16M in 2025. The region's growth is propelled by increasing government initiatives aimed at mental health awareness and the integration of mental health services into primary care. Regulatory support, such as the European Mental Health Action Plan, is catalyzing the adoption of standardized screening tools across member states, enhancing accessibility and quality of care. Leading countries in Europe include Germany, France, and the UK, where mental health services are increasingly prioritized. The competitive landscape features key players like Mind Diagnostics and Headspace Health, who are innovating to meet the growing demand for effective screening solutions. The emphasis on digital health solutions is reshaping the market, making mental health care more accessible to diverse populations.

Asia-Pacific : Rapidly Growing Mental Health Sector

Asia-Pacific is emerging as a rapidly growing region in the Depression Screening Mental Health Market, with a market size of $130.0M in 2025. The growth is driven by increasing awareness of mental health issues, particularly in countries like Australia, Japan, and India. Government initiatives aimed at improving mental health services and reducing stigma are fostering a conducive environment for the adoption of screening tools. The rise of telehealth services is also contributing to market expansion, making mental health care more accessible. The competitive landscape in Asia-Pacific is evolving, with local and international players entering the market. Companies like Lyra Health and Cerebral are expanding their reach, offering innovative solutions tailored to regional needs. The focus on integrating mental health services into primary healthcare systems is expected to drive further growth, as countries prioritize mental well-being in their health agendas.

Middle East and Africa : Developing Mental Health Awareness

The Middle East and Africa region is gradually developing its focus on the Depression Screening Mental Health Market, with a market size of $20.1M in 2025. The growth is primarily driven by increasing awareness of mental health issues and the need for effective screening tools. Governments are beginning to recognize the importance of mental health, leading to initiatives aimed at improving access to mental health services. However, challenges such as stigma and limited resources still hinder progress in this area. Countries like South Africa and the UAE are taking steps to enhance mental health services, with a growing number of organizations focusing on mental health awareness. The competitive landscape is still nascent, but emerging players are beginning to offer innovative solutions. As the region continues to prioritize mental health, the demand for effective screening tools is expected to rise, paving the way for future growth.

Key Players and Competitive Insights

The Depression Screening Mental Health Market is currently characterized by a dynamic competitive landscape, driven by increasing awareness of mental health issues and the growing demand for accessible screening solutions. Key players such as Talkspace (US), BetterHelp (US), and Lyra Health (US) are strategically positioned to leverage digital platforms for delivering mental health services. These companies focus on innovation and technology integration, enhancing user experience through teletherapy and AI-driven assessments. Their collective strategies not only foster competition but also contribute to a more robust market environment, as they continuously adapt to the evolving needs of consumers seeking mental health support.

In terms of business tactics, companies are increasingly localizing their services to cater to diverse populations, optimizing their supply chains to ensure timely access to mental health resources. The market appears moderately fragmented, with a mix of established players and emerging startups. This structure allows for a variety of approaches to depression screening, as companies strive to differentiate themselves through unique service offerings and technological advancements.

In November 2025, Talkspace (US) announced a partnership with a leading health insurance provider to expand its coverage for mental health services. This strategic move is likely to enhance accessibility for users, potentially increasing their market share and reinforcing their position as a leader in the teletherapy space. By aligning with insurance providers, Talkspace may also streamline the reimbursement process, making it easier for clients to access necessary services.

In October 2025, BetterHelp (US) launched a new AI-driven tool designed to personalize therapy recommendations based on user input and behavioral data. This innovation could significantly improve user engagement and satisfaction, as it tailors the therapeutic experience to individual needs. The introduction of such technology not only positions BetterHelp as a forward-thinking player but also reflects a broader trend towards the integration of AI in mental health services, which may redefine user expectations.

In September 2025, Lyra Health (US) expanded its services into the European market, marking a significant step in its global growth strategy. This expansion is indicative of the increasing recognition of mental health as a critical component of overall health, and it suggests that Lyra is keen on tapping into new demographics. By entering Europe, Lyra Health may enhance its competitive edge, as it diversifies its service offerings and adapts to varying regional needs.

As of December 2025, the competitive trends in the Depression Screening Mental Health Market are heavily influenced by digitalization, AI integration, and a growing emphasis on sustainability. Strategic alliances among key players are shaping the landscape, fostering innovation and collaboration. The shift from price-based competition to a focus on technological advancements and reliable supply chains is evident, suggesting that future differentiation will hinge on the ability to innovate and provide high-quality, accessible mental health solutions.

Key Companies in the Depression Screening Mental Health Market market include

Industry Developments

  • In June 2022, Bruker (US) launched enhanced 3d holographic stimulation for optogenetics on its ultima 2pplus multiphoton microscope.
  • In November 2021, Siemens (Ireland) introduced Magnetom Free. It is a cost-effective whole-body MRI scanner designed to enable significantly better access to magnetic resonance imaging.
  • In November 2019, Siemens (Ireland) introduced a new Somatom X.cite CT scanner with a revolutionary user guidance system.

Depression Screening Segmentation

Depression Screening Indication Outlook

  • Major Depressive Disorder
  • Anxiety Distress
  • Bipolar Disorder
  • Psychotic Disorders
  • Others 

Depression Screening Diagnosis Outlook

  • Psychological Tests
  • Blood Tests
  • Pharmacogenomic Testing
  • Others

Depression Screening End User Outlook

  • Hospitals and Clinics
  • Home-based
  • Research and Academic Institutes

Depression Screening Regional Outlook

    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Rest of the World
      • Middle East
      • Africa
      • Latin America

Future Outlook

Depression Screening Mental Health Market Future Outlook

The Depression Screening Mental Health Market is projected to grow at a 5.87% CAGR from 2024 to 2035, driven by increasing awareness and technological advancements.

New opportunities lie in:

  • Integration of AI-driven screening tools in primary care settings.
  • Development of mobile applications for remote depression assessments.
  • Partnerships with employers for workplace mental health programs.

By 2035, the market is expected to be robust, reflecting enhanced screening capabilities and broader accessibility.

Market Segmentation

Depression Screening Mental Health Market End Use Outlook

  • Hospitals
  • Clinics
  • Home Care
  • Telehealth
  • Community Health

Depression Screening Mental Health Market Age Group Outlook

  • Children
  • Adolescents
  • Adults
  • Elderly

Depression Screening Mental Health Market Application Outlook

  • Screening
  • Diagnosis
  • Monitoring
  • Treatment
  • Research

Depression Screening Mental Health Market Method of Screening Outlook

  • Self-Assessment
  • Clinical Assessment
  • Digital Tools
  • Telephonic Screening

Depression Screening Mental Health Market Severity of Depression Outlook

  • Mild
  • Moderate
  • Severe
  • Chronic

Report Scope

MARKET SIZE 2024730.52(USD Million)
MARKET SIZE 2025773.41(USD Million)
MARKET SIZE 20351368.43(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.87% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledPearson (GB), Beck Institute for Cognitive Behavior Therapy (US), Mind Diagnostics (US), Ginger (US), Talkspace (US), Lyra Health (US), Cerebral (US), BetterHelp (US), Headspace Health (US)
Segments CoveredApplication, End Use, Age Group, Method of Screening, Severity of Depression
Key Market OpportunitiesIntegration of digital tools enhances accessibility and efficiency in the Depression Screening Mental Health Market.
Key Market DynamicsRising demand for digital screening tools drives innovation and competition in the Depression Screening Mental Health Market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Market Highlights

Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Leave a Comment

FAQs

What is the projected growth of the Depression Screening market?

The Depression Screening market is the expected increase in total market value of 1.37 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Depression Screening market?

Depression Screening market size was valued at approximately 0.73 billion USD in 2024. This figure will reach 1.37 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Depression Screening market?

Depression Screening market is expected to grow at a CAGR of 5.87% between 2025 and 2035.

How much will the Depression Screening market be worth by 2035?

Depression Screening market is expected to be worth of 1.37 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Depression Screening market perform over the next 10 years?

Over the next 10 years the Depression Screening market is expected to shift from usd billion 0.73 to 1.37 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

How much is the depression screening market?

The Depression Screening Market is anticipated to reach 1.24 billion during the forecast period of 2024-2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions